Epam (EPAM) Q3 earnings: Taking a look at key metrics versus estimates

For the quarter ended September 2026, Epam (EPAM Quick QuoteEPAM - Free Report) reported revenue of $1.43 billion, up 2.3% over the same period last year. EPS came in at $3.51, compared to $3.08 in the year-ago quarter.

The reported revenue represents a surprise of +0.56% over the Zacks Consensus Estimate of $1.42 billion. With the consensus EPS estimate being $3.41, the EPS surprise was +2.93%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Epam performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Headcount: 63,650 versus the two-analyst average estimate of 63,022.
• Delivery professionals: 57,350 versus the two-analyst average estimate of 56,908.
• Revenues by Customer Location- Americas: $809.86 million compared to the $831.88 million average estimate based on two analysts. The reported number represents a change of +0.2% year over year.
• Revenues by Customer Location- APAC: $28.79 million versus $27.93 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -4% change.
• Revenues by Customer Location- EMEA: $587.78 million versus the two-analyst average estimate of $550.22 million. The reported number represents a year-over-year change of +5.8%.
• Revenues by Industry Verticals- Financial Services: $383.97 million compared to the $348.91 million average estimate based on two analysts. The reported number represents a change of +13.7% year over year.
• Revenues by Industry Verticals- Software & Hi-Tech: $199.32 million versus $213.66 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -6.1% change.
• Revenues by Industry Verticals- Life Sciences & Healthcare: $175.02 million versus $162.6 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +9.9% change.
• Revenues by Industry Verticals- Emerging Verticals: $240.44 million compared to the $242.94 million average estimate based on two analysts. The reported number represents a change of -0.5% year over year.
• Revenues by Industry Verticals- Consumer Goods, Retail & Travel: $269.25 million versus $280.55 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -2.5% change.
• Revenues by Contract Type- Time-and-material: $1.11 billion versus the two-analyst average estimate of $1.17 billion. The reported number represents a year-over-year change of -1.2%.
• Revenues by Contract Type- Fixed-price: $315.81 million versus the two-analyst average estimate of $238.67 million. The reported number represents a year-over-year change of +17.8%.